Palisade Capital Management’s Allergan plc AGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AGN
AJ
C
B
JJ
VFA
OPS
Palisade Capital Management's AGN Position: Q2 2020 in Review
Palisade Capital Management sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 7,592 shares — an estimated $1.34M sold.
Palisade Capital Management first reported a position in AGN in Q2 2014 and held it in 12 quarters. The position peaked at $2.8M in Q1 2018. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.
- Palisade Capital Management reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
- Palisade Capital Management sold 7,592 Allergan plc shares in Q2 2020, an estimated $1.34M.
- Palisade Capital Management first reported a position in Allergan plc in Q2 2014 and held it in 12 quarters.
- Palisade Capital Management's Allergan plc position peaked at $2.8M in Q1 2018.
- 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.
Based on Palisade Capital Management's 13F filing for Q2 2020, filed 6 Aug 2020.